Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study Meeting Abstract
| Authors: | Kantarjian, H. M.; Giles, F. J.; Fenaux, P.; Becker, P. S.; Boruchov, A. M.; Bowen, D. T.; Hellström-Lindberg, E.; Larson, R. A.; Lyons, R. M.; Muus, P.; the AMG 531 in Myelodysplastic Syndrome Study Group |
| Abstract Title: | Evaluating safety and efficacy of AMG 531 for the treatment of thrombocytopenic patients with myelodysplastic syndrome (MDS): Preliminary results of a phase 1/2 study |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 365s |
| Language: | English |
| ACCESSION: | WOS:000455043701639 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.7032 |
| Notes: | Meeting Abstract: 7032 -- Source: Wos |
